CWBR
CohBar, Inc.
Set alert
0.41 0.00 0.00%
0.41 Day range 0.41
52-week range unavailable
- Open
- 0.41
- Prev close
- 0.41
- Mkt cap
- 2.32M
- Vol
- 172
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.41
- High
- 0.41
- Forward P/E
- -0.20
- Beta
- 1.55
- Short ratio
- 0.28
- Inst. own
- 9.28%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Sep 30, 2024
- 50-d avg
- 1.13
- 200-d avg
- 2.18
- 1y target
- 0.00
Key statistics
- Market cap
- 2.32M
- Enterprise value
- -10.11M
- Trailing P/E
- 0.00
- Forward P/E
- -0.20
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.24
- EPS (TTM)
- -4.37
- Beta
- 1.55
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -3.50M
- Total cash
- 12.31M
- Total debt
- 0
- Return on equity
- -83.97%
- Shares outstanding
- 2.91M
- Short % of float
- 0.52%
- 50-day average
- 1.13
- 200-day average
- 2.18
Analyst view
Consensus: hold
Hold
Price target (mean) 0.00
Next earnings
Sep 30, 2024
Expected Sep 30, 2024. Consensus EPS estimate 0.00.
Financials — quick view
CWBR Revenue — quarterly 0
CWBR Net income — quarterly -4.33M
CWBR EPS — quarterly -1.49
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Sep 30, 2024 | Jun 1, 2024 | 0.00 | — | — | — |
| Jul 1, 2024 | Mar 1, 2024 | 0.00 | — | — | — |
| Jan 2, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 14, 2023 | Jun 1, 2023 | 0.00 | -1.39 | — | — |
| May 15, 2023 | Mar 1, 2023 | 0.00 | -0.75 | — | — |
About CohBar, Inc.
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases. CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cohbar.com
News
- Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Thursday
- Earnings Scheduled For November 8, 2022
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Thursday
- Stocks That Hit 52-Week Lows On Wednesday
- Earnings Scheduled For August 15, 2022
- Stocks That Hit 52-Week Lows On Wednesday
- Stocks That Hit 52-Week Lows On Monday
Your note
Sign in to keep a note on CWBR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BIUNNO JEFFREY FRANCIS | Chief Financial Officer | Stock Award(Grant) | Jul 31, 2022 | 57,355 |
| SARRET JOSEPH J | Chief Executive Officer | Stock Award(Grant) | Jul 31, 2022 | 151,017 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Quent Capital, LLC | 5.82% | 169,177 | 524.45K | Sep 29, 2023 |
| Vanguard Group Inc | 0.61% | 17,665 | 49.28K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.52% | 15,143 | 42.25K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.46% | 13,360 | 37.27K | Jun 29, 2023 |
| Two Sigma Investments, LP | 0.45% | 13,173 | 36.75K | Jun 29, 2023 |
| Osaic Holdings Inc | 0.08% | 2,459 | 6.86K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.61% | 17,665 | 49.28K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.27% | 7,772 | 21.06K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.12% | 3,590 | 9.73K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.07% | 2,042 | 5.53K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.04% | 1,226 | 3.32K | May 30, 2023 |